GSA Capital Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $939K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $264K | Buy |
|
|||||
|
2024
Q2 | $125K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $161K | Buy |
|
|||||
|
2022
Q3 | $173K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $685K | Buy |
|
|||||
|
2020
Q3 | $66K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $445K | Sell |
|
|||||
|
2016
Q2 | $439K | Sell |
|
|||||
|
2016
Q1 | $483K | Buy |
|
|||||
|
2015
Q4 | $323K | Buy |
|
|||||
|
2015
Q3 | $120K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $58K | Buy |
|